191 related articles for article (PubMed ID: 33964283)
1. Randialic acid B and tomentosolic acid block formyl peptide receptor 1 in human neutrophils and attenuate psoriasis-like inflammation in vivo.
Korinek M; Hsieh PS; Chen YL; Hsieh PW; Chang SH; Wu YH; Hwang TL
Biochem Pharmacol; 2021 Aug; 190():114596. PubMed ID: 33964283
[TBL] [Abstract][Full Text] [Related]
2. Garcinia Multiflora Inhibits FPR1-Mediated Neutrophil Activation and Protects Against Acute Lung Injury.
Tsai YF; Yang SC; Chang WY; Chen JJ; Chen CY; Chang SH; Hwang TL
Cell Physiol Biochem; 2018; 51(6):2776-2793. PubMed ID: 30562761
[TBL] [Abstract][Full Text] [Related]
3. Honokiol suppresses formyl peptide-induced human neutrophil activation by blocking formyl peptide receptor 1.
Liu FC; Yu HP; Syu YT; Fang JY; Lin CF; Chang SH; Lee YT; Hwang TL
Sci Rep; 2017 Jul; 7(1):6718. PubMed ID: 28751674
[TBL] [Abstract][Full Text] [Related]
4. Propofol inhibits superoxide production, elastase release, and chemotaxis in formyl peptide-activated human neutrophils by blocking formyl peptide receptor 1.
Yang SC; Chung PJ; Ho CM; Kuo CY; Hung MF; Huang YT; Chang WY; Chang YW; Chan KH; Hwang TL
J Immunol; 2013 Jun; 190(12):6511-9. PubMed ID: 23670191
[TBL] [Abstract][Full Text] [Related]
5. Bioactive secondary metabolites of a marine Bacillus sp. inhibit superoxide generation and elastase release in human neutrophils by blocking formyl peptide receptor 1.
Yang SC; Lin CF; Chang WY; Kuo J; Huang YT; Chung PJ; Hwang TL
Molecules; 2013 Jun; 18(6):6455-68. PubMed ID: 23736784
[TBL] [Abstract][Full Text] [Related]
6. Dipeptide HCH6-1 inhibits neutrophil activation and protects against acute lung injury by blocking FPR1.
Yang SC; Chang SH; Hsieh PW; Huang YT; Ho CM; Tsai YF; Hwang TL
Free Radic Biol Med; 2017 May; 106():254-269. PubMed ID: 28232203
[TBL] [Abstract][Full Text] [Related]
7. Kan-Lu-Hsiao-Tu-Tan, a traditional Chinese medicine formula, inhibits human neutrophil activation and ameliorates imiquimod-induced psoriasis-like skin inflammation.
Chiang CC; Cheng WJ; Lin CY; Lai KH; Ju SC; Lee C; Yang SH; Hwang TL
J Ethnopharmacol; 2020 Jan; 246():112246. PubMed ID: 31539577
[TBL] [Abstract][Full Text] [Related]
8. Propofol inhibits endogenous formyl peptide-induced neutrophil activation and alleviates lung injury.
Chen CY; Tsai YF; Huang WJ; Chang SH; Hwang TL
Free Radic Biol Med; 2018 Dec; 129():372-382. PubMed ID: 30312762
[TBL] [Abstract][Full Text] [Related]
9. Targeting formyl peptide receptor 1 with anteiso-C13-surfactin for neutrophil-dominant acute respiratory distress syndrome.
Yang SC; Wang YH; Ho CM; Tsai YF; Sung PJ; Lin TE; Hwang TL
Br J Pharmacol; 2023 Aug; 180(16):2120-2139. PubMed ID: 36929355
[TBL] [Abstract][Full Text] [Related]
10. 4-Aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-ones as N-formyl peptide receptor 1 (FPR1) antagonists.
Kirpotina LN; Schepetkin IA; Khlebnikov AI; Ruban OI; Ge Y; Ye RD; Kominsky DJ; Quinn MT
Biochem Pharmacol; 2017 Oct; 142():120-132. PubMed ID: 28690139
[TBL] [Abstract][Full Text] [Related]
11. Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives.
Schepetkin IA; Khlebnikov AI; Kirpotina LN; Quinn MT
Int Immunopharmacol; 2016 Aug; 37():43-58. PubMed ID: 26382576
[TBL] [Abstract][Full Text] [Related]
12. AZ2158 is a more potent formyl peptide receptor 1 inhibitor than the commonly used peptide antagonists in abolishing neutrophil chemotaxis.
Forsman H; Wu Y; Mårtensson J; Björkman L; Granberg KL; Dahlgren C; Sundqvist M
Biochem Pharmacol; 2023 May; 211():115529. PubMed ID: 37004778
[TBL] [Abstract][Full Text] [Related]
13. Functional selective FPR1 signaling in favor of an activation of the neutrophil superoxide generating NOX2 complex.
Lind S; Dahlgren C; Holmdahl R; Olofsson P; Forsman H
J Leukoc Biol; 2021 Jun; 109(6):1105-1120. PubMed ID: 33040403
[TBL] [Abstract][Full Text] [Related]
14. Identification of C-terminal phosphorylation sites of N-formyl peptide receptor-1 (FPR1) in human blood neutrophils.
Maaty WS; Lord CI; Gripentrog JM; Riesselman M; Keren-Aviram G; Liu T; Dratz EA; Bothner B; Jesaitis AJ
J Biol Chem; 2013 Sep; 288(38):27042-27058. PubMed ID: 23873933
[TBL] [Abstract][Full Text] [Related]
15. A non-peptide receptor inhibitor with selectivity for one of the neutrophil formyl peptide receptors, FPR 1.
Cevik-Aras H; Kalderén C; Jenmalm Jensen A; Oprea T; Dahlgren C; Forsman H
Biochem Pharmacol; 2012 Jun; 83(12):1655-62. PubMed ID: 22410002
[TBL] [Abstract][Full Text] [Related]
16. Mitocryptide-2: Identification of Its Minimum Structure for Specific Activation of FPR2-Possible Receptor Switching from FPR2 to FPR1 by Its Physiological C-terminal Cleavages.
Marutani T; Nishino K; Miyaji T; Kamada K; Ohura K; Kiso Y; Mukai H
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920954
[TBL] [Abstract][Full Text] [Related]
17. Antagonism of human formyl peptide receptor 1 (FPR1) by chromones and related isoflavones.
Schepetkin IA; Kirpotina LN; Khlebnikov AI; Cheng N; Ye RD; Quinn MT
Biochem Pharmacol; 2014 Dec; 92(4):627-41. PubMed ID: 25450672
[TBL] [Abstract][Full Text] [Related]
18. Stable formyl peptide receptor agonists that activate the neutrophil NADPH-oxidase identified through screening of a compound library.
Forsman H; Kalderén C; Nordin A; Nordling E; Jensen AJ; Dahlgren C
Biochem Pharmacol; 2011 Feb; 81(3):402-11. PubMed ID: 21095183
[TBL] [Abstract][Full Text] [Related]
19. Chemokines and mitochondrial products activate neutrophils to amplify organ injury during mouse acute liver failure.
Marques PE; Amaral SS; Pires DA; Nogueira LL; Soriani FM; Lima BH; Lopes GA; Russo RC; Avila TV; Melgaço JG; Oliveira AG; Pinto MA; Lima CX; De Paula AM; Cara DC; Leite MF; Teixeira MM; Menezes GB
Hepatology; 2012 Nov; 56(5):1971-82. PubMed ID: 22532075
[TBL] [Abstract][Full Text] [Related]
20. The potential impacts of formyl peptide receptor 1 in inflammatory diseases.
Yang SC; Hwang TL
Front Biosci (Elite Ed); 2016 Jun; 8(3):436-49. PubMed ID: 27100350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
